Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Obstet Gynecol Reprod Biol ; 136(2): 160-4, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17467877

RESUMO

OBJECTIVES: The objective of this prospective study was to determine the reliability of fetal pulse oximetry (FPO) in cases of abnormal fetal heart rate (FHR) pattern and fetal oxygen saturation (FSpO(2)) below 30%. STUDY DESIGN: Three hundred and one deliveries complicated by abnormal FHR pattern were monitored with both CTG and FPO. Cases of FSpO(2) values below 30% (n=52) formed the study group and those above 30% (n=249) were the control group. pH and base excess (BE) in the umbilical cord artery, 5-min Apgar score, and pH and BE in the newborn were measured and compared. Statistical analysis included the Epi info 2002 program, Chi-squared test, and linear regression. RESULTS: FSpO(2) values were consequently below 30% in 52 and above 30% in 249 cases. When FSpO(2) values were below 30%, umbilical pH was significantly lower than in controls (P<0.01), while other parameters were not significantly different. If the time interval between the measurement of the first low (<30%) FSpO(2) value and delivery did not exceed 32.4+/-2.5 min, umbilical pH and Apgar scores did not show fetal acidosis. CONCLUSION: Our findings suggest that FPO is a reliable method of estimating fetal condition and may help reduce the number of cesarean sections performed due to abnormal FHR tracings.


Assuntos
Acidose/diagnóstico , Sangue Fetal/metabolismo , Hipóxia Fetal/diagnóstico , Oxigênio/sangue , Acidose/sangue , Animais , Cardiotocografia , Feminino , Sofrimento Fetal/sangue , Sofrimento Fetal/diagnóstico , Hipóxia Fetal/sangue , Frequência Cardíaca Fetal , Humanos , Trabalho de Parto , Oximetria , Gravidez , Resultado da Gravidez , Estudos Prospectivos , Fatores de Tempo
2.
Am J Obstet Gynecol ; 193(3 Pt 1): 864-5, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16150290

RESUMO

Recombinant human-activated protein C (rhAPC) has been suggested to treat sepsis. We present the case of a 19-year-old pregnant patient at the 18th week of gestation with septic shock syndrome that originated from urinary tract infection and was successfully treated with rhAPC.


Assuntos
Fibrinolíticos/uso terapêutico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Proteína C/uso terapêutico , Choque Séptico/tratamento farmacológico , Adulto , Feminino , Humanos , Gravidez , Segundo Trimestre da Gravidez , Proteínas Recombinantes/uso terapêutico , Choque Séptico/etiologia , Infecções Urinárias/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA